Dr John David Mosier, DO - Medicare Family Practice in Herington, KS

Dr John David Mosier, DO is a medicare enrolled "Family Medicine" physician in Herington, Kansas. He graduated from medical school in 1994 and has 30 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Hospital District No 1 Marion Co and his current practice location is 6 North Broadway, Herington, Kansas. You can reach out to his office (for appointments etc.) via phone at (785) 366-6457.

Dr John David Mosier is licensed to practice in Kansas (license number 05-25866) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1982665287.

Contact Information

Dr John David Mosier, DO
6 North Broadway,
Herington, KS 67449
(785) 366-6457
Not Available



Physician's Profile

Full NameDr John David Mosier
GenderMale
SpecialityFamily Practice
Experience30 Years
Location6 North Broadway, Herington, Kansas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr John David Mosier graduated from medical school in 1994
  NPI Data:
  • NPI Number: 1982665287
  • Provider Enumeration Date: 03/28/2006
  • Last Update Date: 04/26/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 8022048008
  • Enrollment ID: I20050818001022

Medical Identifiers

Medical identifiers for Dr John David Mosier such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1982665287NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 05-25866 (Kansas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Luke Hospital & Living CenterMarion, KSHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Hospital District No 1 Marion Co751792319611

News Archive

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John David Mosier allows following entities to bill medicare on his behalf.
Entity NameDr. John D. Mosier, Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912030271
PECOS PAC ID: 7012960727
Enrollment ID: O20050222000885

News Archive

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Read more Medical News

› Verified 9 days ago

Entity NameHospital District No 1 Marion Co
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144355793
PECOS PAC ID: 7517923196
Enrollment ID: O20050428000824

News Archive

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Read more Medical News

› Verified 9 days ago

Entity NameHospital District No 1 Marion Co
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1326087966
PECOS PAC ID: 7517923196
Enrollment ID: O20061104000413

News Archive

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Read more Medical News

› Verified 9 days ago

Entity NameHillsboro Hospital Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1710525985
PECOS PAC ID: 4587090121
Enrollment ID: O20200407002361

News Archive

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John David Mosier is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr John David Mosier, DO
Po Box 425,
Herington, KS 67449-0425

Ph: (785) 366-6457
Dr John David Mosier, DO
6 North Broadway,
Herington, KS 67449

Ph: (785) 366-6457

News Archive

Clinical Cancer Research publishes results of Aduro's ANZ-100 and CRS-207 Phase 1 studies

Aduro BioTech, Inc. is pleased to announce the publication of two therapeutic cancer vaccine Phase 1 studies in Clinical Cancer Research. In the article, which was featured as one of the highlights of the issue, Dr. Dung Le et al. reported that intravenous administration of ANZ-100 and CRS-207 was well tolerated in subjects with advanced, treatment-refractory cancers.

'Beach envy' triggers enquiries for liposuction

The Harley Medical Group has reported thousands of enquiries for liposuction over the last month as a wave of what is termed 'beach envy' - jealousy of other women's bodies - hit holidaymakers.

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

For nearly 60 years, Pyrazinamide (PZA) has been used in conjunction with other medications to treat tuberculosis (TB), but scientists did not fully understand how the drug killed TB bacteria. PZA plays a unique role in shortening the duration of current TB therapy to six months and is used frequently to treat multi-drug resistant TB.

Read more News

› Verified 9 days ago


Family Medicine Doctors in Herington, KS

Dr. Richard Uhlig, D.O.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1005 N B St, Herington, KS 67449
Phone: 785-258-5130    Fax: 785-258-5129
Dr. Randolph Richard Whitely, M.D.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1005 N B St, Herington, KS 67449
Phone: 785-258-2100    Fax: 785-258-2104

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.